Mads Kjolby Selected Research

camostat

10/2021	Determination of camostat and its metabolites in human plasma - Preservation of samples and quantification by a validated UHPLC-MS/MS method.
5/2021	Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
3/2021	Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
2/2021	Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
8/2020	Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mads Kjolby Research Topics

Disease

7	Atherosclerosis 01/2019 - 12/2014
6	COVID-19 01/2022 - 08/2020
3	Infections 05/2021 - 08/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2015
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2017
3	Hypercholesterolemia 10/2017 - 09/2010
2	Vascular Calcification 01/2022 - 04/2016
2	Inflammation (Inflammations) 01/2018 - 12/2014
1	Phenylketonurias (Phenylketonuria) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 10/2021
1	Human Influenza (Influenza) 02/2021
1	Chest Pain (Chest Pains) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Pancreatitis 08/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Insulin Resistance 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Diabetes Mellitus 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018
1	Calcinosis 04/2016
1	Abdominal Aortic Aneurysm 04/2015
1	Myocardial Infarction 04/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 04/2015
1	Atherosclerotic Plaque (Atheroma) 12/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2014
1	Parkinson Disease (Parkinson's Disease) 01/2013

Drug/Important Bio-Agent (IBA)

9	sortilinIBA 01/2022 - 09/2010
5	camostatIBA 10/2021 - 08/2020
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
4	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2020
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019 - 04/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2014
3	CytokinesIBA 01/2022 - 12/2014
3	Pharmaceutical PreparationsIBA 10/2021 - 02/2014
3	Lipoproteins (Lipoprotein)IBA 01/2018 - 09/2010
2	Peptide Hydrolases (Proteases)FDA Link 03/2021 - 08/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2021 - 08/2020
2	CholesterolIBA 01/2021 - 12/2014
2	low density lipoprotein inhibitorIBA 01/2019 - 08/2017
2	oxidized low density lipoproteinIBA 01/2019 - 08/2017
1	Caseins (Casein)FDA Link 01/2022
1	caseinomacropeptideIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	InterferonsIBA 01/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2022
1	Serine Proteases (Serine Protease)IBA 05/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	trkB ReceptorIBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	ProgranulinsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Apolipoproteins E (ApoE)IBA 10/2017
1	LDL CholesterolIBA 04/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 06/2014
1	Nerve Growth Factors (Neurotrophins)IBA 01/2013
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013
1	LDL Receptors (LDL Receptor)IBA 09/2010

Therapy/Procedure

2	Therapeutics 08/2020 - 01/2020